New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 21, 2013
10:10 EDTPICO, TTI, WEN, FNSR, JDSU, MRC, CXO, HURN, BKW, VIPS, SGYP, SCMP, ICPT, IRWD, PTN, MKGAY, REGI, IT, XOM, DAR, CVX, AMRNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Amarin (AMRN) initiated with a Perform at Oppenheimer... Chevron (CVX) initiated with an Outperform at Wells Fargo... Darling (DAR) initiated with an Outperform at Wedbush... Exxon Mobil (XOM) initiated with a Market Perform at Wells Fargo... Gartner (IT) initiated with a Buy at Stifel... Intercept (ICPT) initiated with an Outperform at Oppenheimer... Ironwood (IRWD) initiated with an Outperform at Credit Suisse... Merck KGaA (MKGAY) initiated with a Sell at Goldman... Palatin Tech (PTN) initiated with an Overweight at Piper Jaffray... Renewable Energy (REGI) initiated with an Outperform at Wedbush... Sucampo (SCMP) initiated with a Neutral at Credit Suisse... Synergy Pharmaceuticals (SGYP) initiated with an Outperform at Credit Suisse... Tetra Technologies (TTI) initiated with an Equal Weight at Stephens... Wendy's (WEN) initiated with a Market Perform at Wells Fargo... Finisar (FNSR) initiated with a Buy at Craig-Hallum... JDSU (JDSU) initiated with a Buy at Craig-Hallum... MRC Global (MRC) initiated with a Buy at Maxim... Concho Resources (CXO) re-initiated with a Buy at BofA/Merrill... Huron (HURN) initiated with a Buy at Stifel... Burger King (BKW) initiated with a Market Perform at Wells Fargo... PICO Holdings (PICO) initiated with an Outperform at Northland Securities... Vipshop (VIPS) initiated with a Buy at Citigroup.
News For AMRN;CVX;DAR;XOM;IT;ICPT;IRWD;PTN;MKGAY;REGI;SCMP;SGYP;TTI;WEN;FNSR;JDSU;MRC;CXO;HURN;BKW;VIPS;PICO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 17, 2014
10:51 EDTBKWOptions with increasing implied volatility
Options with increasing implied volatility: COV DISH HLT QEP GREK BKW BYI LLY DTV TIBX
08:54 EDTCVXChevron adds drillship to deepwater operations in Gulf of Mexico
Chevron Corporation (CVX) announced that the Pacific Sharav, a deepwater drillship built to Chevron's specifications, has arrived in the Gulf of Mexico to work under a five-year contract with Pacific Drilling (PACD). The Pacific Sharav is an upgraded Dual-Load-Path, Samsung-12000-design, dynamically-positioned drillship, specially modified to accept a Dual Gradient Drilling System, and able to operate in moderate environments and water depths up to 12,000 feet. The Pacific Sharav has commenced operations in the Keathley Canyon area.
08:48 EDTCVXChevron arranges FID for IDD, postpones second phase, Reuters says
Subscribe for More Information
October 16, 2014
15:10 EDTIRWDAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
13:54 EDTXOM, CVXGulf states to oppose OPEC oil production ceiling cut, WSJ says
Despite the recent turmoil in the oil market, Gulf nations including Saudi Arabia, Kuwait and the United Arab Emirates are seen as opposing OPEC oil-production ceiling cuts at next month's meeting, says the Wall Street Journal. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link
08:08 EDTAMRNAmarin sees cash and cash equivalents of $135.4M at September 30
Subscribe for More Information
08:02 EDTIRWDIronwood announces initiation of Phase II linaclotide trial
Ironwood Pharmaceuticals (IRWD) announced the initiation of a Phase II clinical trial evaluating linaclotide for the treatment of adults suffering from opioid-induced constipation. Data are expected in the second half of 2015. The clinical trial is being conducted jointly by Ironwood and Actavis plc (ACT), Ironwood’s co-development and co-promotion partner for linaclotide in the United States. Linaclotide is a guanylate cyclase-C agonist approved by the FDA for the treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Linaclotide is not currently approved for the treatment of OIC. The randomized, double-blind, placebo-controlled, multi-site Phase II clinical trial is expected to enroll approximately 240 adult patients with chronic, non-cancer pain who have been receiving a stable dose of an opioid analgesic and suffer from constipation, defined as fewer than three spontaneous bowel movements per week. Patients will be randomized to receive 145 mcg of linaclotide, 290 mcg of linaclotide, or placebo for eight weeks. The primary endpoint of the trial is an increase in SBM frequency. Additionally, a number of secondary endpoints and exploratory analyses intended to inform future development plans are included in the study design.
October 15, 2014
10:23 EDTAMRNAmarin management to meet with Oppenheimer
Meeting to be held on the West Coast on October 22 hosted by Oppenheimer.
09:21 EDTICPTIntercept pullback a buying opportunity, says Summer Street
Subscribe for More Information
07:44 EDTCVX, XOMExxon, Shell behind rivals in lowering greenhouse gas emissions, WSJ reports
Subscribe for More Information
07:24 EDTICPTIntercept management to meet with Deutsche Bank
Subscribe for More Information
07:12 EDTTTITetra Technologies initiated with a Buy at ISI Group
Subscribe for More Information
07:05 EDTMRCMRC Global initiated with a Buy at ISI Group
Subscribe for More Information
October 14, 2014
09:19 EDTCVXChevron delays $12B deepwater project after gas discovery, Jakarta Post says
PT Chevron Pacific Indonesia, a unit of Chevron, has submitted a letter requesting the postponement of its $12B Indonesia Deepwater Development project as it revise its calculations on the project following the discovery of a new gas reserve that has increased the project’s monetizing value, reported The Jakarta Post, citing an official with the Energy and Mineral Resources Ministry. Reference Link
09:04 EDTXOMStatoil, Exxon Mobil announce additional discovery offshore Tanzania
Statoil (STO) and co-venturer Exxon Mobil (XOM) announced that the Giligiliani-1 exploration well has resulted in a new natural gas discovery offshore Tanzania. The discovery of an additional 1.2 trillion cubic feet of natural gas in place in the Giligiliani-1 well brings the total of in-place volumes up to approximately 21 tcf in block 2. The Giligiliani-1 discovery is the venture’s seventh discovery in block 2. Statoil operates the licence on block 2 on behalf of Tanzania Petroleum Development Corporation and has a 65% working interest. ExxonMobil Exploration and Production Tanzania Limited holds the remaining 35%.
06:47 EDTSCMPSucampo signs amendment to license agreement for AMITIZA with Takeda
Subscribe for More Information
October 13, 2014
07:15 EDTXOMNational Association of Corporate Directors to hold a conference
Subscribe for More Information
06:36 EDTCVX, XOMSaudi Arabia content to let oil prices stay low, Reuters reports
Subscribe for More Information
October 12, 2014
13:53 EDTXOM, CVXKuwaiti Minister says OPEC unlikely to cut production, WSJ says
Subscribe for More Information
13:45 EDTCVX, XOMSaudis take aggressive oil measures in Europe, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use